Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose vs Standard Dose Influenza Vaccine in IBD
NCT02461758Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Oct 2016
- Primary completion
- Jun 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of influenza vaccine in influenza (4 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Influenza Antibody Concentrations. Started Oct 2016; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02461758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02461758.